Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jaguar Health Inc (NQ: JAGX ) 1.270 +0.090 (+7.63%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jaguar Health Inc < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption August 16, 2023 Via ACCESSWIRE Jaguar Health Reports Second Quarter 2023 Financial Results August 14, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea August 09, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease August 08, 2023 Via ACCESSWIRE Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea August 07, 2023 Via ACCESSWIRE Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC) June 20, 2023 Via ACCESSWIRE Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs" June 08, 2023 Via ACCESSWIRE Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40% May 23, 2023 Via ACCESSWIRE Earnings Scheduled For August 14, 2023 August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. Via Benzinga Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates August 10, 2023 Via ACCESSWIRE Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC August 03, 2023 Via ACCESSWIRE REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th August 02, 2023 Via ACCESSWIRE Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS) August 01, 2023 Via ACCESSWIRE In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon July 27, 2023 Via ACCESSWIRE Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs July 26, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" July 25, 2023 Via ACCESSWIRE Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 24, 2023 Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. Via Benzinga Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders July 07, 2023 Via ACCESSWIRE Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket June 29, 2023 Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday. Via Benzinga Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease June 28, 2023 Via ACCESSWIRE First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research June 26, 2023 Via ACCESSWIRE Jaguar Health Launching AI-Driven Social Media Disease Awareness Education Series Regarding Cancer Therapy-Related Diarrhea in Dogs and People June 22, 2023 Via ACCESSWIRE Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference June 15, 2023 Via ACCESSWIRE Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice in Supportive Care June 14, 2023 Via ACCESSWIRE European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits June 07, 2023 Via ACCESSWIRE Jaguar Announces Over-Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea May 25, 2023 Via ACCESSWIRE Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory Board May 24, 2023 Via ACCESSWIRE Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4) May 19, 2023 Via ACCESSWIRE Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel May 16, 2023 Via ACCESSWIRE Nasdaq Rises 75 Points; Tower Semiconductor Posts Upbeat Q1 Results May 15, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.07% to 33,325.35 while the NASDAQ rose 0.62% to 12,360.60. The S&P... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.